[Progresses in the field of pharmacology. 3].
D000700:Analgesics / Q000138:chemical synthesis / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000138:chemical synthesis; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis; D000927:Anticonvulsants / Q000138:chemical synthesis; D000959:Antihypertensive Agents / Q000138:chemical synthesis; D000970:Antineoplastic Agents / Q000138:chemical synthesis; D002490:Central Nervous System / Q000187:drug effects; D050356:Lipid Metabolism; D009467:Neuromuscular Depolarizing Agents / Q000138:chemical synthesis / Q000494:pharmacology; D010276:Parasympatholytics / Q000138:chemical synthesis; D010525:Peripheral Nerves / Q000187:drug effects; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis*; D013566:Sympathomimetics / Q000138:chemical synthesis; D014527:Uric Acid / Q000378:metabolism
D000700:Analgesics; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D009467:Neuromuscular Depolarizing Agents; D010276:Parasympatholytics; D004364:Pharmaceutical Preparations; D013566:Sympathomimetics; D014527:Uric Acid
Fortschritte auf dem Gebiet der Arzneimittelentwicklung. 3.